Scientists at UC San Francisco have identified key protein interactions associated with profound autism by mapping more than 1,000 molecular connections stemming from known autism risk genes. The research, published in the journal Science, represents a significant advance in understanding the biological mechanisms underlying the condition, which is characterized by severe intellectual disability, minimal verbal communication, and often co-occurring medical conditions such as epilepsy.
The study builds on progress made in recent years identifying individual genes harboring mutations found in people with profound autism. However, researchers had struggled to translate these genetic discoveries into effective treatments. The new work addresses this gap by examining how proteins produced from these high-risk genes interact with one another at the molecular level. The research team, led by Dr. Matthew State and Nevan Krogan at UCSF, combined traditional laboratory techniques with artificial intelligence technology, specifically Google DeepMind’s AlphaFold system, to accelerate the identification of protein interactions that would have previously taken years to map.
The methodology involved introducing 100 proteins from high-risk autism genes into laboratory cells to identify which additional proteins attached to them. Researchers then used AI systems to determine which proteins directly interacted with one another. Subsequently, they introduced genetic mutations observed in patients with profound autism to assess how these changes affected protein function, conducting experiments in both frog models and in organoids—lab-grown tissues that simulate human brain tissue.
The analysis revealed that while hundreds of different rare, high-risk autism genes operate through distinct mechanisms, many converge on shared biological pathways related to early brain development, including synapse construction and neuronal development timing. This convergence suggests potential therapeutic targets. Experts in the field have characterized the molecular atlas as an unprecedented resource that should accelerate drug development efforts. The research provides families and advocates dealing with profound autism with renewed hope for eventual therapeutic interventions.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI